Related Experiment Video
Updated: Feb 16, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs
Qinyong Gu1, Zeli Zhang1, Christoph G W Gertzen1,2
1Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Abstract:
Members of the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC3 [A3]) family of DNA cytidine deaminases are intrinsic restriction factors against retroviruses. In felids such as the domestic cat (Felis catus), the A3 genes encode the A3Z2, A3Z3, and A3Z2Z3 antiviral cytidine deaminases. Only A3Z3 and A3Z2Z3 inhibit viral infectivity factor (Vif)-deficient feline immunodeficiency virus (FIV). The FIV Vif protein interacts with Cullin (CUL), Elongin B (ELOB), and Elongin C (ELOC) to form an E3 ubiquitination complex to induce the degradation of feline A3s. However, the functional domains in FIV Vif for the interaction with Cullin are poorly understood. Here, we found that the expression of dominant negative CUL5 prevented the degradation of feline A3s by FIV Vif, while dominant negative CUL2 had no influence on the degradation of A3. In coimmunoprecipitation assays, FIV Vif bound to CUL5 but not CUL2. To identify the CUL5 interaction site in FIV Vif, the conserved amino acids from positions 47 to 160 of FIV Vif were mutated, but these mutations did not impair the binding of Vif to CUL5. By focusing on a potential zinc-binding motif (K175-C161-C184-C187) of FIV Vif, we found a conserved hydrophobic region (174IR175) that is important for the CUL5 interaction. Mutation of this region also impaired the FIV Vif-induced degradation of feline A3s. Based on a structural model of the FIV Vif-CUL5 interaction, the 52LW53 region in CUL5 was identified as mediating binding to FIV Vif. By comparing our results to the human immunodeficiency virus type 1 (HIV-1) Vif-CUL5 interaction surface (120IR121, a hydrophobic region that is localized in the zinc-binding motif), we suggest that the CUL5 interaction surface in the diverse HIV-1 and FIV Vifs is evolutionarily conserved, indicating a strong structural constraint. However, the FIV Vif-CUL5 interaction is zinc independent, which contrasts with the zinc dependence of HIV-1 Vif.IMPORTANCE Feline immunodeficiency virus (FIV), which is similar to human immunodeficiency virus type 1 (HIV-1), replicates in its natural host in T cells and macrophages that express the antiviral restriction factor APOBEC3 (A3). To escape A3s, FIV and HIV induce the degradation of these proteins by building a ubiquitin ligase complex using the viral protein Vif to connect to cellular proteins, including Cullin 5. Here, we identified the protein residues that regulate this interaction in FIV Vif and Cullin 5. While our structural model suggests that the diverse FIV and HIV-1 Vifs use conserved residues for Cullin 5 binding, FIV Vif binds Cullin 5 independently of zinc, in contrast to HIV-1 Vif.
Insights
Feline immunodeficiency virus (FIV) Vif protein degrades feline APOBEC3 (A3) antiviral proteins by binding Cullin 5. Researchers identified key FIV Vif residues for CUL5 binding, revealing conserved interactions with HIV-1 Vif but a zinc-independent mechanism in FIV.
Area of Science:
- Virology and retroviral restriction factors
- Molecular biology and protein-protein interactions
- Immunology and host-pathogen interactions
Background:
- APOBEC3 (A3) enzymes are crucial intrinsic defense mechanisms against retroviral infections, including feline immunodeficiency virus (FIV).
- FIV's viral infectivity factor (Vif) counteracts A3 proteins by recruiting them for degradation via a Cullin-based E3 ubiquitin ligase complex.
- The specific domains within FIV Vif responsible for interacting with Cullin proteins, particularly Cullin 5 (CUL5), remain largely uncharacterized.
Purpose of the Study:
- To elucidate the functional domains of FIV Vif involved in the interaction with Cullin proteins, specifically CUL5.
- To identify the key residues in FIV Vif and CUL5 that mediate their binding.
- To compare the FIV Vif-CUL5 interaction mechanism with that of human immunodeficiency virus type 1 (HIV-1) Vif.
Main Methods:
- Expression of dominant-negative Cullin mutants (CUL2 and CUL5) to assess their impact on feline A3 degradation.
- Coimmunoprecipitation assays to determine direct binding between FIV Vif and Cullin proteins.
- Site-directed mutagenesis of conserved amino acid residues in FIV Vif and structural modeling to pinpoint interaction sites.
Main Results:
- Dominant-negative CUL5, but not CUL2, prevented FIV Vif-mediated degradation of feline A3s, indicating a specific role for CUL5.
- FIV Vif directly binds to CUL5, and a conserved hydrophobic region (174IR175) within FIV Vif is critical for this interaction.
- Structural analysis identified the 52LW53 region in CUL5 as important for binding FIV Vif, and this interaction is zinc-independent, unlike HIV-1 Vif.
Conclusions:
- The study identifies critical residues in FIV Vif and CUL5 that mediate their interaction, essential for the degradation of feline A3 antiviral proteins.
- The findings reveal conserved structural features in the Vif-CUL5 interaction across different lentiviruses, suggesting evolutionary constraints.
- A key distinction is the zinc-independent binding of FIV Vif to CUL5, contrasting with the zinc-dependent mechanism observed in HIV-1 Vif.
More Related Videos
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Pinching-off of Coated Vesicles

